go to main content
15 August 2019

Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available and running from 2014 to 2020. This summer, no less than 8 proposals for the Radboudumc have been accepted, 4 of them even as a coordinator. 

We are proud to announce that the following proposals have been accepted for RIMLS researchers. Congratulations to you all. 


Project title: Personalized immunotherapy in sepsis: a precision medicine based approach. (1.660 k€)
Coordinator: Mihai Netea, theme Infectious diseases and global health

Project title: Host directed medicine in invasive fungal infection. (2.811 k€)
Coordinator: Frank van de Veerdonk, theme Infectious diseases and global health

Project title: Brain injury in the premature born infant: stem cell regeneration research network. (322 k€) 
Partner: Irma Joosten, theme Inflammatory diseases

Project title: Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia. (785 k€.)
Partner: Mihai Netea, theme Infectious diseases and global health. 

Project title: DIAMONDS - Diagnosis and Management of Febrile Illness using RNA Personalised Multiclass Signature Diagnosis. 
Partners: Ronald de Groot and Marien de Jonge, theme Infectious diseases and global health

Related news items

RIMLS awards call for nominations

19 October 2021 RIMLS awards several prizes to stimulate and honor our (young) researchers. Upcoming awards are Supervisor of the Year, Best Master Thesis, Best Publication, Best Image and more. Send your nominations now before 24 November 2021. read more

Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection

17 February 2021 In a review in Cell Mihai Netea, Frank van de Veerdonk, Reinout van Crevel and Jorge Dominguez Andres propose that induction of trained immunity by whole-microorganism vaccines may represent an important tool for reducing susceptibility to and severity of SARS-CoV-2. read more

ZonMw grants to study optimal use of COVID-19 vaccines in patients with impaired immune systems

3 February 2021 How do people with reduced immunity, especially kidney patients, react to a COVID-19 vaccination? And how can patients with peripheral arterial disease be helped by DNA testing? Our researchers received grants from ZonMw to make these studies possible. read more

New insight into the effect of hydroxychloroquine undermines its use in corona

11 June 2020 Researchers at Radboud university medical center have discovered an as yet unknown effect of hydroxychloroquine. Raphael Duivenvoorden was interviewed in the program Op1 at NPO1 to elaborate on the findings. It seems unlikely that chloroquine has beneficial effect in corona infections. read more

RIMLS PhD grants awarded to eight RIMLS (j)PI's

12 September 2019 Recently, RIMLS held an internal call for Radboudumc junior researcher (PhD) positions. Congratulations for all the awardees and all the best in conducting the research projects. read more

Four Veni grants for junior RIMLS researchers

22 July 2019 Four junior researchers, affiliated to the RIMLS, have each received a Veni grant of 250,000 Euro from NWO. Our researchers received this prestigious grant for their remarkable and original talent and their ability to carry out innovative research. read more